Antibiotic testing in people on kidney dialysis
Treatments studied
Part of Infections, Kidney & urinary clinical trials.
This trial studies how common antibiotics move through the body when someone is on kidney replacement therapy (dialysis), including when dialysis starts during treatment. The results may help doctors choose the right antibiotic dose and timing for better infection treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older
- Be receiving an infection antibiotic as part of usual care: meropenem, ertapenem, cefepime, colistin, ceftazidime/avibactam, ceftolozane/tazobactam, or piperacillin/tazobactam
- Take the antibiotic while on dialysis (IHD or CRRT), or start dialysis within the course of the antibiotic
- Have a hemoglobin above 70 g/L and no blood transfusion in the last 24 hours
- Not be pregnant and not have severe weight extremes (BMI less than 18 or greater than 35)
- Be able to give consent (you, your next of kin, or a legal representative)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how much certain antibiotics (meropenem, linezolid, and daptomycin) are removed when you're on a special blood-filtering machine called continuous renal replacement therapy (CRRT) for severe kidney injury. The results could help doctors give the right dose of antibiotics to treat infections effectively.
This study tests an IV antibiotic (cefiderocol/xeruborbactam) in people with different levels of kidney function, including those on dialysis. It aims to see how the drug is processed by the body and whether it is safe.
This trial tests whether taking preventive antibiotics (or a placebo sugar pill) can lower the risk of infections in people who receive hemodialysis through a catheter. It may help protect you from serious catheter-related infections, but you must be able to follow the study’s medicine and consent rules.
This trial compares two common antibiotic combinations to see which one is less likely to cause kidney injury in hospitalized patients. You may be eligible if you need treatment with vancomycin plus either piperacillin-tazobactam or cefepime.
This study looks at how well a continuous kidney replacement therapy removes a common antibiotic combination (piperacillin and tazobactam) from the blood in intensive care patients. It may help doctors better dose the antibiotic for patients on this type of dialysis.
This trial tests if giving a specific antibiotic can help prevent bloodstream infections in people who recently had a kidney transplant. It is for patients who have a significant amount of bacteria in their urine within the first month after surgery.
Hear when a new Renal Replacement Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.